Urge Urinary Incontinence: Clinical Trials

3 trials for Urge Urinary Incontinence, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 21Terminated 1

Follow Urge Urinary Incontinence: new trials by email Literature Review of Urge Urinary Incontinence trials Research Report on Urge Urinary Incontinence

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bryophyllum Pinnatum Versus Solifenacin Versus Placebo for Overactive Bladder
Bryophyllum - Overactive Bladder, Urge Urinary Incontinence
Phase 2 / Phase 3TerminatedUniversity of Zurich92014-05-012017-10-26
Transcutaneous Mechanical Nerve Stimulation in the Treatment of Incontinence
Transcutaneous mechanical nerve stimulation - Stress Urinary Incontinence, Urge Urinary Incontinence
Phase 3TerminatedCopenhagen University Hospital at Herlev42011-05-012013-05-24
Refractory Urge Incontinence and Botox Injections
Botulinum Toxin A, bladder detrusor muscle injection, Vehicle saline as placebo - Urinary Incontinence, Detrusor Overactivity
Phase 3TerminatedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)872006-06-012011-01-11

Narrower conditions

Urinary Incontinence, Urge (3)  ·  Urinary Bladder, Overactive (2)  ·  Urinary Incontinence (1)  ·  Urinary Incontinence, Stress (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Lower Urinary Tract Symptoms (3)  ·  Male Urogenital Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Urination Disorders (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Urological Manifestations (3)  ·  Urinary Bladder Diseases (2)  ·  Urinary Incontinence (2)

Interventions

Botulinum Toxins, Type A (1)

Sponsors

Copenhagen University Hospital at Herlev (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  University of Zurich (1)

Countries

Denmark (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Linda Brubaker, MD (1)  ·  Mikkel Fode, MD (1)

Results publications

PMID 18499184, PMID 23218404